SBC Medical announces alliance with NeuroBrain Dynamics to advance clinic profitability through medical AI
SBC•SBC Medical Group will make a minority equity investment in NeuroBrain Dynamics and co-develop six medical AI solutions, with priority sales rights in Japan and South Korea. It plans to introduce generative AI across 287 clinics and begin rolling out three tools from mid-2027.
1. AI alliance
SBC Medical Group announced a capital and business alliance with NeuroBrain Dynamics, including a minority equity investment on November 13, 2026, and plans to co-develop six medical AI solutions. SBC Medical secured priority sales rights in Japan and South Korea.
2. Clinic rollout
The company plans to introduce generative AI solutions for revenue growth and cost reduction across 287 clinics in Japan and overseas, and offer the solutions to external medical institutions as it expands B2B business in Asia. Rollouts of an AI concierge guidance tool, a MySBC recommendation feature and CPP are scheduled to start in mid-2027.
